Curve - cultivated beef
| Reference number | |
| Coordinator | Curve Biotech AB |
| Funding from Vinnova | SEK 2 047 955 |
| Project duration | November 2024 - March 2026 |
| Status | Completed |
| Venture | Acceleration of deep tech companies |
| Call | Acceleration of deep tech companies 2024 |
Important results from the project
The focus for phase 2 was continuation of cell growth in suspension in a bioreactor and validation of the techno economic opportunity. Proving technical feasibility and customer acceptance. The targets of succesful proliferation of mammalian cells in a small bioreactor, validating the functionality of Curve´s patentapplied novel pilot technology BIOBRIC at Lund University and signing LOI´s with potential co-developement partner and customer was reached.
Expected long term effects
Phase 2 has strengthened Curve´s technical platform and strategic outlook. It has improved operational preparedness, expanded the market perspective, and reinforced a disciplined approach to validation and risk management, all of which will guide Curve’s continued business roll out. Long-term it strengthens the food- and biotech ecosystem in Sweden, supports export-oriented innovation, transforming the food value chain by enabling circular, resource-efficient and resilient production systems.
Approach and implementation
This cross-disciplinary business requires specific expertise, open innovation, and simultaneous investments to activate the value chain transformation. Performance, scalability, and cost efficiency was evaluated in parallel. Data from these trials will guide technology selection and feed directly into the project plan for further development. Unexpected events did occur that delayed timeline, such as the software issues with the control units and dependencies on external partners.